Year end 2011 financials for esrx showed total assets of $15.6 million of which $7 million was goodwill and intangible assets. $5 million of the assets appear to be new borrowing. All this against liabilities of $13 million,$7 miilion of which is debt.
This looks like a very thin balance sheet which I'd think would only get worse after the mhs purchase.
wag on the other hand has a very strong financial position (also stronger than cvs ) and would appear to be in a better position if it comes to a "who blinks first" showdown.
Can anyone tell me why I'm wrong on this evaluation?